Cargando…

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease

BACKGROUND: The role of the fecal microbiota composition for the postoperative disease course of patients with Crohn’s disease (CD) who have undergone ileocecal resection remains to be established. In this study, we investigated if the fecal microbiota composition, determined by a high throughput te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strömbeck, Anna, Lasson, Anders, Strid, Hans, Sundin, Johanna, Stotzer, Per-Ove, Simrén, Magnus, Magnusson, Maria K., Öhman, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197162/ https://www.ncbi.nlm.nih.gov/pubmed/32366222 http://dx.doi.org/10.1186/s12876-020-01281-4

Ejemplares similares

Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
por: Öhman, Lena, et al.
Publicado: (2021)

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
por: Klingberg, Eva, et al.
Publicado: (2019)

Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease
por: Mavroudis, Georgios, et al.
Publicado: (2019)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
por: Iribarren, Cristina, et al.
Publicado: (2022)

Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids
por: Holst, Luiza Moraes, et al.
Publicado: (2022)

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects
por: Sundin, Johanna, et al.
Publicado: (2018)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

Health-related quality of life in patients with long-standing ulcerative colitis in remission
por: Mavroudis, Georgios, et al.
Publicado: (2022)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

Endoscopic treatment of Crohn-related strictures with a self-expandable stent compared with balloon dilation: a prospective, randomised, controlled study
por: Hedenström, Per, et al.
Publicado: (2021)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Effects of the long-term storage of human fecal microbiota samples collected in RNAlater
por: Tap, Julien, et al.
Publicado: (2019)

Postoperative results and complications of fecal diversion for anorectal Crohn’s disease
por: Kuroki, Hirosuke, et al.
Publicado: (2022)

A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome
por: Polster, Annikka, et al.
Publicado: (2021)

Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission
por: Maasfeh, Lujain, et al.
Publicado: (2021)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

The fecal microbiota as a biomarker for disease activity in Crohn’s disease
por: Tedjo, Danyta. I., et al.
Publicado: (2016)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease
por: Ling Lundström, Maria, et al.
Publicado: (2023)

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome
por: Iribarren, Cristina, et al.
Publicado: (2021)

Aloe barbadensis Mill. extract improves symptoms in IBS patients with diarrhoea: post hoc analysis of two randomized double-blind controlled studies
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease
por: Galazzo, Gianluca, et al.
Publicado: (2019)

Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
por: Chen, Liang, et al.
Publicado: (2022)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

Risk of Fecal Diversion in Complicated Perianal Crohn’s Disease
por: Mueller, M. H., et al.
Publicado: (2007)

Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers
por: Malíčková, Karin, et al.
Publicado: (2017)

Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's Disease
por: Dige, Anders, et al.
Publicado: (2018)

The ileal fungal microbiota is altered in Crohn's disease and is associated with the disease course
por: Olaisen, Maya, et al.
Publicado: (2022)

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
por: Matuszczyk, Małgorzata, et al.
Publicado: (2022)

Postoperative course of Crohn disease according to timing of bowel resection: Results from the CONNECT Study
por: Lee, Ji Min, et al.
Publicado: (2018)

The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease
por: Kennedy, Nicholas A, et al.
Publicado: (2018)

Medical therapies for postoperative Crohn’s disease
por: Shah, Ravi S., et al.
Publicado: (2021)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Can Fecal Microbial Transplant Effectively Treat Crohn's Disease?
por: Dai, Cong, et al.
Publicado: (2015)

Temporary Fecal Diversion in the Management of Colorectal and Perianal Crohn's Disease
por: Mennigen, Rudolf, et al.
Publicado: (2015)

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
por: Kennedy, Nicholas A., et al.
Publicado: (2019)

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
por: Doherty, Matthew K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r5rtrej8bpp2jaq3soqmttt5v7